Celldex Therapeutics (CLDX) Debt Ratio (2010 - 2013)

Celldex Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.04 for Q1 2013.

• In Q1 2013, Debt Ratio fell 59.64% year-over-year to 0.04; the TTM figure through Mar 2013 stood at 0.04 (down 59.64% YoY), while the FY2012 annual figure was 0.09, down 41.56% from the prior year.
• Debt Ratio was 0.04 for Q1 2013 at Celldex Therapeutics, down from 0.09 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.16 in Q2 2012 to a low of 0.04 in Q1 2013.
• Historically, Debt Ratio has averaged 0.11 across 4 years, with a median of 0.11 in 2012.
• The sharpest annual moves came in 2011 and 2013: Debt Ratio jumped 69.91% in 2011, then sank 59.64% in 2013.
• A 4-year view of Debt Ratio shows it stood at 0.09 in 2010, then surged by 69.91% to 0.15 in 2011, then slumped by 41.56% to 0.09 in 2012, then plunged by 50.37% to 0.04 in 2013.
• The last three Debt Ratio figures came in at 0.04 (Q1 2013), 0.09 (Q4 2012), and 0.11 (Q3 2012), per Business Quant data.